Kr. Brunden et al., PH-DEPENDENT BINDING OF SYNTHETIC BETA-AMYLOID PEPTIDES TO GLYCOSAMINOGLYCANS, Journal of neurochemistry, 61(6), 1993, pp. 2147-2154
The senile plaques found within the cerebral cortex and hippocampus of
the Alzheimer disease brain contain beta-amyloid peptide (Abeta) fibr
ils that are associated with a variety of macromolecular species, incl
uding dermatan sulfate proteoglycan and heparan sulfate proteoglycan.
The latter has been shown recently to bind tightly to both amyloid pre
cursor protein and Abeta, and this binding has been attributed largely
to the interaction of the core protein of heparan sulfate proteoglyca
n with Abeta and its precursor. Here we have examined the ability of s
ynthetic Abetas to bind to and interact with the glycosaminoglycan moi
eties of proteoglycans. Abeta(1-28) associates with heparin, heparan s
ulfate, dermatan sulfate, and chondroitin sulfate. The interaction of
these sulfated polysaccharides with the amyloid peptide results in the
formation of large aggregates that are readily sedimented by centrifu
gation. The ability of both Abeta(1-28) and Abeta(1-40) to bind glycos
aminoglycans is pH-dependent, with increasing interaction as the pH va
lues fall below neutrality and very little binding at pH 8.0. The pH p
rofile of heparin-induced aggregation of Abeta(1-28) has a midpoint pH
of approximately 6.5, suggesting that one or more histidine residues
must be protonated for binding to occur. Analysis of the Abeta sequenc
e reveals a consensus heparin-binding domain at residues 12-17, and th
is motif contains histidines at positions 13 and 14 that may be involv
ed in the interaction with glycosaminoglycans. This hypothesis is supp
orted by the following observations: (a) Abeta(13-17) binds tightly to
a heparin affinity column at pH 4.0, but not at pH 8.0; and (b) an Ab
eta(13-17) in which histidine residues 13 and 14 have been replaced wi
th serines does not bind to a heparin column at either pH 8.0 or 4.0.
Together, the data indicate that Abeta is capable of binding to the gl
ycosaminoglycan chains of proteoglycans, and such an interaction may b
e relevant to the etiology and pathology of Alzheimer's disease.